Plasma hepatocyte growth factor as a marker for small-for-gestational age fetuses

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 110, Issue 1, 2003, Pages 20-25

  Tjoa, May Lee ^a   Mulders, Monique A M ^a   Van Vugt, John M G ^a   Blankenstein, Marinus A ^a   Oudejans, Cees B M ^a   Van Wijk, Inge J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hepatocyte growth factor; Plasma; Preeclampsia

Indexed keywords

SCATTER FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; PREDICTION; PREECLAMPSIA; PROTEIN BLOOD LEVEL; SMALL FOR DATE INFANT;

EID: 0042427762     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00083-6     Document Type: Article

References (26)

1. Barker D.J., Osmond C., Simmonds S.J., Wield G.A. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ. 306:1993;422-426.
2. Godfrey K.M. Maternal regulation of fetal development and health in adult life. Eur. J. Obstet. Gynecol. Reprod. Biol. 78:1998;141-150.
3. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., van Assche A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J. Obstet. Gynaecol. 101:1994;669-674.
4. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J. Clin. Invest. 99:1997;2152-2164.
5. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J. Obstet. Gynaecol. 93:1986;1049-1059.
6. Sheppard B.L., Bonnar J. Uteroplacental hemostasis in intrauterine fetal growth retardation. Semin Thromb. Hemost. 25:1999;443-446.
7. Uehara Y., Minowa O., Mori C.et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:1995;702-705.
8. Kauma S.W., Bae-Jump V., Walsh S.W. Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia. J. Clin. Endocrinol. Metab. 84:1999;4092-4096.
9. Kloosterman G.J. On intrauterine growth. The significance of prenatal care. Int. J. Gynaecol. Obstet. 8:1970;895-912.
10. van Wijk I.J., van Vugt J.M.G., Mulders M.A.M., Konst A.A., Weima S.M., Oudejans C.B.M. Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. Am. J. Obstet. Gynecol. 174:1996;871-878.
11. Horibe N., Okamoto T., Itakura A.et al. Levels of hepatocyte growth factor in maternal serum and amniotic fluid. Am. J. Obstet. Gynecol. 173:1995;937-942.
12. Clark D.E., Salvig J.D., Smith S.K., Charnock-Jones D.S. Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies. Placenta. 19:1998;671-673.
13. Tjoa M.L., van Vugt J.M.G., Mulders M.A.M., Schutgens R.B., Oudejans C.B.M., van Wijk I.J. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet. Gynecol. 98:2001;600-607.
14. Furugori K., Kurauchi O., Itakura A.et al. Levels of hepatocyte growth factor and its messenger ribonucleic acid in uncomplicated pregnancies and those complicated by preeclampsia. J. Clin. Endocrinol. Metab. 82:1997;2726-2730.
15. Somerset D.A., Li X.F., Afford S.et al. Ontogeny of hepatocyte growth factor (HGF) and its receptor (c-met) in human placenta: reduced HGF expression in intrauterine growth restriction. Am. J. Pathol. 153:1998;1139-1147.
16. Kurauchi O., Itakura A., Ando H., Kuno N., Mizutani S., Tomoda Y. The concentration of hepatocyte growth factor (HGF) in human amniotic fluid at second trimester: relation to fetal birth weight. Horm. Metab. Res. 27:1995;335-338.
17. Ohnishi Y., Yamashiro C., Yanagihara T., Hata T. Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth. Hum. Reprod. 14:1999;2625-2628.
18. Kilby M.D., Afford S., Li X.F., Strain A.J., Ahmed A., Whittle M.J. Localisation of hepatocyte growth factor and its receptor (c-met) protein and mRNA in human term placenta (JID 9000468). Growth Factors. 13:1996;133-139.
19. Aoki S., Hata T., Manabe A., Miyazaki K. Decreased maternal circulating hepatocyte growth factor (HGF) concentrations in pregnancies with small for gestational age infants. Hum. Reprod. 13:1998;2950-2953.
20. Chan A.M., Rubin J.S., Bottaro D.P., Hirschfield D.W., Chedid M., Aaronson S.A. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science. 254:1991;1382-1385.
21. Cioce V., Csaky K.G., Chan A.M.et al. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J. Biol. Chem. 271:1996;13110-13115.
22. Jakubczak J.L., LaRochelle W.J., Merlino G. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Mol. Cell. Biol. 18:1998;1275-1283.
23. Rubin J.S., Day R.M., Breckenridge D.et al. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J. Biol. Chem. 276:2001;32977-32983.
24. Lietha D., Chirgadze D.Y., Mulloy B., Blundell T.L., Gherardi E. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J. 20:2001;5543-5555.
25. Kingdom J.C., Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta. 18:1997;613-621.
26. Iioka H. Clinical use of human hepatocyte growth factor in the early detection of HELLP syndrome. Gynecol. Obstet. Invest. 41:1996;103-105.